Below are the major policies that experts, federal agencies, and independent reviews have credited as impactful.
What it was: A publicāprivate partnership launched in 2020 to accelerate vaccine development, testing, manufacturing, and distribution. Why it mattered:
What experts say: OWS is widely recognizedāacross administrationsāas a major scientific and logistical success.
January 2020: Restrictions on travel from ChinaMarch 2020: Restrictions on travel from EuropeImpact: These actions did not stop COVID from entering the U.S., but CDC and NIH analyses concluded they slowed early spread and bought time for vaccine development.
The Trump administration used the DPA to increase production of:
This helped address early shortages and expanded national stockpiles.
Congress (with White House support) passed:
These bills created the testing and vaccineādistribution systems that continued under Biden.
Despite political differences, the Biden administration kept or expanded several Trumpāera COVID policies.
Biden kept the OWS structure and funding in place, renaming it the COVIDā19 Response Team. The vaccine contracts, supply chains, and distribution networks created in 2020 remained the backbone of the 2021 rollout.
Biden kept the Trumpāera contracts with:
These contracts were essential to the mass vaccination campaign.
Biden continued using the DPA to expand production of:
This was a direct continuation of Trumpās DPA actions.
Biden kept the Trumpāera travel restrictions in place for months, then expanded them to additional countries during new variants.
Biden kept in place:
All of these originated under Trump.